However, there are many ways to treat cancer, such as targeted drugs. For a long time, many cancer patients were intimidated by the high cost, and even had to go to India to buy imitation drugs, so there was the film Dying to Survive.
Fortunately, some targeted drugs can also be reimbursed by medical insurance. But if you think targeted drugs are the most expensive cancer treatment, it is wrong. What we are going to talk about today is immunotherapy for diseases.
On June 22nd, 20021,a CAR-T cell therapy product in China was approved for sale by National Medical Products Administration, China, and it was also the first CAR-T cell therapy product approved for marketing in China. This CAR-T cell therapy product, which is approved for marketing in National Medical Products Administration, China, is developed by Fosun Kate, and can be used to treat second-line and above refractory large B-cell lymphoma. This drug has been paid great attention since it was released, because of its surprising cost. The treatment cost of this CAR-T cell therapy product actually reached1200,000 once. For billionaires,1200,000 is nothing. But what about the average working family? I don't know, how many families can take out that much money at a time?
What kind of medicine is this? It's incredibly expensive. In fact, clearly speaking, CAR-T is a cutting-edge method for the diagnosis and treatment of cancer, and it is not a drug. It is called chimeric antigen receptor T cell immunotherapy, and the English full name is chimericantignerceptort-cell immunotherapy. In the laboratory, professional technicians activate T cells according to genetic engineering, and install navigation and positioning equipment CAR (Malignant Tumor Chimeric Antigen Receptor) to transform the general "warrior occupation" of T cells into "super soldier", that is, CAR-T cells. He uses his own "navigation and positioning equipment CAR" to professionally identify cancer cells in the body, and releases a large number of various utility factors through immunization to achieve the effect of treating tumors. Because CAR-T is individualized treatment, and it must be very advanced in preparation technology, so the cost of one-time treatment is particularly expensive.
Up to now, this expensive treatment has been applied to 200 patients in China. Many people will think that such an expensive treatment is worthwhile if it can cure cancer. In fact, CAR-T is not useful for every cancer. For example, Aquilencel developed by Fosun Kate is only suitable for the treatment of second-line and above refractory large B-cell lymphoma, and the actual effect on general cancer is not so good.